An observational study in Cardiac Arrest and Reanimation, sponsored by Nantes University Hospital. Recruiting at 12 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-25.
Sponsored by Nantes University Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 106 studies in Heart Arrest with a site in France — 32 open to participants now, 33 under way, 3 of them phase 3. Heart Arrest · France.
Among the 106 studies in Heart Arrest with a site in France, this one is the 37th largest by planned enrollment of the 47 observational ones that give a count, is one of 10 that started in 2025, is one of 47 observational ones, reaches primary completion later than 14 of the 32 other live ones, and was the 92nd registered.
927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.
Browse Heart Arrest studies →32 of the 106 studies in Heart Arrest with a site in France are open now. Recruiting first, the newest first:
Nantes University Hospital · Sites in France, Belgium, Guadeloupe
Ages 18+
University Hospital, Toulouse · Sites in France
Ages 18+
University Hospital, Toulouse · Sites in France
Ages 18+ · Healthy volunteers
Versailles Hospital · Sites in France
Ages 18+
Poitiers University Hospital · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
106 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 10 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 200 across 376 observational studies indexed under Heart Arrest.
Median enrollment 106 across the 59 interventional studies, 150 across the 47 observational. Of the 62 that completed or were terminated, 3 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 106 have an industry lead sponsor. The 10 most frequent:
Nantes University Hospital is the lead sponsor of 839 studies on the registry; 189 are open to participants now.
Nantes University Hospital has 5 studies filed under Heart Arrest — fewer than ten, so there is no comparison to draw.
8 of the studies in Heart Arrest with a site in France that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06835491Phase 3Versailles HospitalProphylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm | 2027-01-15 |
| NCT03594318Versailles HospitalVersailles Hospital Cardiac Arrest Registry | 2026-12 |
| NCT06387225Nantes University HospitalEarly and Objective Assessment of Neurological Prognosis in Cardiac Arrest Patients | 2027-05-31 |
| NCT05961488CHU de ReimsPerformance of Coronary CT Angiography to Rule Out Coronary Artery Disease After Out-of-hospital Cardiac Arrest | 2027-06 |
| NCT06780722Nantes University HospitalStudy of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Procedure | 2027-06-06 |
Add all 8 to your calendar (.ics) → With an account.
Among the 106 studies in Heart Arrest with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Evaluation of the level of hypoxemia during the occurrence of cardiocirculatory arrest during a Maastricht III organ donation procedure.
Evaluation of the level of hypoxemia during the occurrence of cardiocirculatory arrest during a Maastricht III organ donation procedure.
Patients who may be candidates for an organ donation procedure in the event of death in intensive care following the implementation of a procedure to discontinue active therapies.
FOR THE DONORS :
Inclusion Criteria :
Exclusion Criteria :
FOR THE RECEIVER
Inclusion Criteria :
Exclusion Criteria :
- Patients under guardianship, curatorship or legal protection
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
* The first sample is taken at the start of the therapeutic stop. * The second sample is taken when the mean arterial pressure drops to 45mmHg. * The third sample is taken when circulatory arrest occurs. * The fourth sample is taken at the start of extracorporeal circulation. These four samples will be destroyed at the end of the study.
PaO2 level
PaO2 level and its 95% confidence interval in the event of circulatory cardiac arrest, defined as a pulse pressure below 5 mmHg, during a Maastricht III procedure.
Time frame: 24 hours
Spo2 Level
Define the level of Spo2 (and its 95% confidence interval) at the time of cardiocirculatory arrest during a Maastricht III procedure.
Time frame: 24 hours
Time between occurrence of first episode of pulsed oxygen saturation below 95% and onset of cardiocirculatory arrest
Define the time (and its 95% confidence interval) between the occurrence of the first first episode of pulsed oxygen saturation below 95% and the onset of cardio-circulatory arrest defined by absence of pulsed pressure below 5 mmHg.
Time frame: 24 hours
Correlation between the rate of delayed recovery of renal function in the recipient and the presence of hypoxemia at the time of cardiocirculatory arrest in the donor.
Delayed recovery of renal function will be confirmed if the recipient undergoes dialysis within the first 7 days after transplantation. Hypoxemia is defined as a PaO2 less than or equal to the median value.
Time frame: 7 days
Started Dec 2025 (actual). Primary completion is estimated for Jun 2027, 17 months after the start.
Of 169 non-industry observational studies under Heart Arrest, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 96. This study's planned 17 months is below that.
Counting every sponsor, half of 176 studies reached it within 41 months; a quarter within 18 and three quarters within 90.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.